About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Trials in Dallas | 17,468 Studies Near You | Clareo Health

Clinical Trials LocationsDallas

Clinical Trials in Dallas

Discover 17,468 clinical trials near Dallas, Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Filters

Sort by

Status

Recruiting(Enrolling)

Not yet recruiting

Active, not recruiting

Enrolling by invitation(Enrolling)

Completed

Terminated

Phase

Early Phase 1

Phase 1

Phase 1/Phase 2

Phase 2

Phase 2/Phase 3

Phase 3

Phase 4

Not Applicable

Eligibility

Accepts healthy volunteers

Showing 16461-16480 of 17,468 trials

COMPLETEDPhase 4< 1 mile

To Determine if Diphenhydramine Works for Nasal Congestion at Two Different Doses

NCT00648973

The study was to determine if the drug worked to relieve nasal congestion experienced by people with seasonal allergies.

Nasal Congestion

Johnson & Johnson Consumer and Personal Products Worldwide1,021 participantsStarted Nov 2006

Austin, Texas, United States • Austin, Texas, United States • Austin, Texas, United States +9 more locations

COMPLETEDPhase 3< 1 mile

Efficacy and Safety of Different Doses of Indacaterol

NCT01079130

This study compared the 14-day bronchodilator efficacy of indacaterol with that of placebo and salmeterol

Novartis Pharmaceuticals511 participantsStarted Feb 2010

Glendale, Arizona, United States • Scottsdale, Arizona, United States • Encinitas, California, United States +68 more locations

Find Trials by Condition in Dallas

Breast Cancerin Dallas Lung Cancerin Dallas Prostate Cancerin Dallas Colorectal Cancerin Dallas Melanomain Dallas Leukemiain Dallas Lymphomain Dallas Pancreatic Cancerin Dallas Ovarian Cancerin Dallas Brain Cancerin Dallas Diabetesin Dallas

Data from ClinicalTrials.govTerms

COMPLETEDPhase 3< 1 mile

Comparison of Raloxifene and Lasofoxifene - A Randomized, Blinded Study of These Drugs and Placebo on Bone Loss

NCT00163137

To compare the effects of 2 years of lasofoxifene treatment with 2 years of raloxifene 60 mg/day use and 2 years of placebo use on bone mineral density (BMD) of the lumbar spine.

Ligand Pharmaceuticals540 participantsStarted May 2003

Albany, California, United States • Berkeley, California, United States • La Jolla, California, United States +69 more locations

WITHDRAWNPhase 2< 1 mile

Study of MB07811 in Subjects With Hypercholesterolemia

NCT00879112

A Phase 2 randomized, placebo controlled study assessing the efficacy, safety, and tolerability of MB07811 given orally to subjects with primary hypercholesterolemia for 12 weeks followed by a 6-week off drug phase.

Hypercholesterolemia

Ligand Pharmaceuticals80 participantsStarted Apr 2009

San Diego, California, United States • Jacksonville, Florida, United States • Pembroke Pines, Florida, United States +8 more locations

COMPLETEDNA< 1 mile

A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients

NCT00002307

To compare stavudine (d4T) and zidovudine (AZT) in slowing the progression of HIV disease. To compare the antiviral activity of d4T versus AZT as measured by plasma levels of p24 antigen and HIV viremia, and their relative efficacy by improvement and/or absence of adverse changes over time in laboratory parameters associated with HIV infection. To compare the safety of oral doses of d4T to AZT in patients with HIV infection.

Bristol-Myers Squibb

Tucson, Arizona, United States • Berkeley, California, United States • Los Angeles, California, United States +42 more locations

COMPLETEDPhase 4< 1 mile

Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive Patients

NCT00744237

This study will evaluate the effects of nebivolol on glycemic control compared with metoprolol and HCTZ in patients with hypertension and type 2 diabetes mellitus

HypertensionType 2 Diabetes Mellitus

Forest Laboratories231 participantsStarted Aug 2008

Athens, Alabama, United States • Huntsville, Alabama, United States • Bell Gardens, California, United States +62 more locations

COMPLETEDPhase 218 miles

Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol

NCT01156844

This study assessed the bronchodilator efficacy of three different regimens of indacaterol in patients with asthma

Persistent Asthma

Novartis Pharmaceuticals191 participantsStarted Mar 2010

Anniston, Alabama, United States • Cypress, California, United States • Fresno, California, United States +27 more locations

COMPLETEDPhase 331 miles

12-week Efficacy of Indacaterol

NCT01072448

This 12-week study evaluated the efficacy and safety of indacaterol versus placebo.

Chronic Obstructive Pulmonary Disease

Novartis323 participantsStarted Jan 2010

Peoria, Arizona, United States • Pine Bluff, Arkansas, United States • Buena Park, California, United States +59 more locations

COMPLETEDPhase 331 miles

Safety and Tolerability Study Comparing Sodium Oxybate Given as an Oral Solution to a Single-blinded Combination of Oral Tablets Plus Oral Solution in Subjects With Fibromyalgia

NCT00803023

To compare the safety and tolerability of sodium oxybate given as a combination of an oral solution and oral tablets for 4 weeks in subjects with fibromyalgia (FM).

Jazz Pharmaceuticals129 participantsStarted Mar 2010

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Anaheim, California, United States +29 more locations

COMPLETED31 miles

TBTC NAA Study: Pilot Study of Surrogate Markers for Outcome of TB Treatment

NCT00023439

This is a pilot study to evaluate the performance of several nucleic acid amplification methodologies in the diagnosis and management of active tuberculosis

Centers for Disease Control and Prevention300 participantsStarted May 2000

Little Rock, Arkansas, United States • Los Angeles, California, United States • San Francisco, California, United States +11 more locations

COMPLETEDPhase 1/2190 miles

Safety, Efficacy, and Pharmacokinetics (PK) Study of Trans Sodium Crocetinate (TSC) in Patients With Intermittent Claudication

NCT00725881

The purpose of this study is to evaluate the safety and pharmacokinetics of multiple, once-daily, intravenous doses of trans sodium crocetinate (TSC). The effectiveness of TSC in alleviating the symptoms of intermittent claudication (IC) will also be assessed.

Intermittent Claudication

Diffusion Pharmaceuticals Inc48 participantsStarted Aug 2008

Birmingham, Alabama, United States • Santa Rosa, California, United States • Stanford, California, United States +4 more locations

COMPLETEDPhase 3225 miles

Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease

NCT00846586

This study assessed the efficacy and safety of indacaterol (150 µg once daily \[od\]) when combined with tiotropium (18 µg od) versus tiotropium (18 µg od) treatment alone in patients with chronic obstructive pulmonary disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Novartis Pharmaceuticals1,134 participantsStarted Mar 2009

Birmingham, Alabama, United States • Mobile, Alabama, United States • Scottsdale, Arizona, United States +134 more locations

TERMINATEDPhase 2225 miles

A Study for Adults With Plaque Psoriasis

NCT01018810

In this study, we will evaluate clinical activity, safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of 5 LY2525623 dosing groups compared to placebo in adults with plaque psoriasis.

Eli Lilly and Company8 participantsStarted Dec 2009

Mobile, Alabama, United States • Peoria, Arizona, United States • Hot Springs, Arkansas, United States +25 more locations

COMPLETEDPhase 3252 miles

A Study to Compare the Lung Effect of Indacaterol and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD)

NCT00900731

This study compared the lung effects of indacaterol to those of tiotropium in patients with moderate to severe chronic obstructive pulmonary disease (COPD) over a 12 week period.

Chronic Obstructive Pulmonary Disease

Novartis Pharmaceuticals1,598 participantsStarted Jun 2009

Birmingham, Alabama, United States • Jasper, Alabama, United States • Phoenix, Arizona, United States +209 more locations

COMPLETEDPhase 3454 miles

Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA)

NCT00048542

This is a multicenter, Phase 3 randomized, placebo-controlled study designed to evaluate adalimumab in children 4 to 17 years old with polyarticular juvenile idiopathic arthritis (JIA) who are either methotrexate (MTX) treated or non-MTX treated.

Arthritis, Juvenile Idiopathic

Abbott171 participantsStarted Sep 2002

Birmingham, Alabama, United States • Los Angeles, California, United States • Stanford, California, United States +28 more locations

COMPLETEDPhase 3770 miles

Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer

NCT00520676

The purpose of this study is to compare the combination of pemetrexed and carboplatin with the combination of docetaxel and carboplatin in terms of survival without Grade 3 or 4 toxicity in previously untreated patients with locally advanced or metastatic non-small cell lung cancer (NSCLC).

Non-Small Cell Lung Cancer

Eli Lilly and Company260 participantsStarted Oct 2007

Ballarat, Victoria, Australia • Frankston, Victoria, Australia • Wendouree, Victoria, Australia +17 more locations

COMPLETEDPhase 2811 miles

Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma

NCT00006219

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. Dehydroepiandrosterone and clarithromycin may be effective in preventing multiple myeloma. PURPOSE: Randomized phase II trial to compare the effectiveness of dehydroepiandrosterone with that of clarithromycin in treating patients who may be at a high risk of developing multiple myeloma.

Multiple Myeloma and Plasma Cell Neoplasm

Mayo ClinicStarted Aug 2000

Scottsdale, Arizona, United States • Jacksonville, Florida, United States • Rochester, Minnesota, United States

COMPLETEDPhase 1885 miles

Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme

NCT00509301

RATIONALE: Cotara® is an experimental new treatment that links a radioactive isotope (iodine 131) to a targeted monoclonal antibody. This monoclonal antibody is designed to bind tumor cells and deliver radiation directly to the center of the tumor mass while minimizing effects on normal tissues. Cotara® thus literally destroys the tumor "from the inside out." This may be an effective treatment for glioblastoma multiforme, a malignant type of brain cancer. PURPOSE: This trial is studying the safety and radiation distribution of Cotara® in patients with recurrent glioblastoma multiforme.

Recurrent Glioblastoma Multiforme

Peregrine Pharmaceuticals12 participantsStarted Nov 2006

Phoenix, Arizona, United States • Cleveland, Ohio, United States • Philadelphia, Pennsylvania, United States +1 more locations

COMPLETEDPhase 31100 miles

Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Using Salmeterol as Active Control

NCT00567996

This study evaluated the safety and efficacy of 26 weeks treatment with indacaterol, placebo or salmeterol in patients with chronic obstructive pulmonary disease.

Chronic Obstructive Pulmonary Disease (COPD)

Novartis1,002 participantsStarted Nov 2007

Edmonton, Canada • Edmonton, Canada • London, Canada +125 more locations

COMPLETEDPhase 31110 miles

Two-Dose Methotrexate for Ectopic Pregnancy

NCT00194272

This study examines the safety and acceptability of a novel "two dose" regimen of methotrexate to treat ectopic pregnancy.

Ectopic Pregnancy

University of Pennsylvania100 participantsStarted Mar 2001

Los Angeles, California, United States • Miami, Florida, United States • Philadelphia, Pennsylvania, United States

PreviousPage 824 of 874Next

Heart Diseasein Dallas